High-fructose corn syrup-induced hepatic dysfunction in rats: improving effect of resveratrol

European Journal of Nutrition

Volumn 54, Issue 6, 2015, Pages 895-904

  Sadi, Gokhan ^a   Ergin, Volkan ^b   Yilmaz, Guldal ^b   Pektas, M Bilgehan ^b   Yildirim, O Gokhan ^b   Menevse, Adnan ^b   Akar, Fatma ^b  

^a KARAMANOGLU MEHMETBEY UNIVERSITY   (Turkey)

^b GAZI UNIVERSITY   (Turkey)

Author keywords

eNOS; FASN; Hepatic lipid; High fructose corn syrup; IRS 1; Resveratrol; SIRT1; SREBP 1c

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CORN SYRUP; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FATTY ACID SYNTHASE; INDUCIBLE NITRIC OXIDE SYNTHASE; INSULIN RECEPTOR SUBSTRATE 1; INSULIN RECEPTOR SUBSTRATE 2; MESSENGER RNA; RESVERATROL; SIRTUIN 1; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; TRIACYLGLYCEROL; INSULIN; INSULIN RECEPTOR SUBSTRATE; IRS1 PROTEIN, RAT; SIRT1 PROTEIN, RAT; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; STILBENE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CALORIC INTAKE; CONTROLLED STUDY; DRUG EFFICACY; FATTY LIVER; LIPID LIVER LEVEL; LIPID STORAGE; LIPOGENESIS; LIVER DYSFUNCTION; LIVER FUNCTION; LIVER HISTOLOGY; LIVER PROTECTION; LIVER WEIGHT; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; ANIMAL; CHEMISTRY; DRUG EFFECTS; DRUG-INDUCED LIVER INJURY; ENZYME ACTIVATION; ENZYMOLOGY; GENE EXPRESSION; GENETICS; LIVER; METABOLISM; SIGNAL TRANSDUCTION; WISTAR RAT;

ANIMALS; BODY WEIGHT; DRUG-INDUCED LIVER INJURY; ENZYME ACTIVATION; FATTY ACID SYNTHASE, TYPE I; GENE EXPRESSION; HIGH FRUCTOSE CORN SYRUP; INSULIN; INSULIN RECEPTOR SUBSTRATE PROTEINS; LIVER; MALE; NITRIC OXIDE SYNTHASE TYPE III; RATS; RATS, WISTAR; RNA, MESSENGER; SIGNAL TRANSDUCTION; SIRTUIN 1; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; STILBENES; TRIGLYCERIDES;

EID: 84944445428     PISSN: 14366207     EISSN: 14366215     Source Type: Journal    
DOI: 10.1007/s00394-014-0765-1     Document Type: Article

References (38)

1. Stanhope KL, Havel PJ (2010) Fructose consumption: recent results and their potential implications. Ann N Y Acad Sci 1190:15–24. doi:10.1111/j.1749-6632.2009.05266.x
2. Heiss SN (2013) “Healthy” discussions about risk: The corn refiners association’s strategic negotiation of authority in the debate over high fructose corn syrup. Public Underst Sci 22:219–235. doi:10.1177/0963662511402281
3. Collison KS, Saleh SM, Bakheet RH et al (2009) Diabetes of the liver: the link between nonalcoholic fatty liver disease and HFCS-55. Obesity (Silver Spring) 17:2003–2013. doi:10.1038/oby.2009.58
4. Bocarsly ME, Powell ES, Avena NM, Hoebel BG (2010) High-fructose corn syrup causes characteristics of obesity in rats: increased body weight, body fat and triglyceride levels. Pharmacol Biochem Behav 97:101–106. doi:10.1016/j.pbb.2010.02.012
5. Akar F, Uludağ O, Aydın A et al (2012) High-fructose corn syrup causes vascular dysfunction associated with metabolic disturbance in rats: protective effect of resveratrol. Food Chem Toxicol 50:2135–2141. doi:10.1016/j.fct.2012.03.061
6. Babacanoglu C, Yildirim N, Sadi G et al (2013) Resveratrol prevents high-fructose corn syrup-induced vascular insulin resistance and dysfunction in rats. Food Chem Toxicol 60:160–167. doi:10.1016/j.fct.2013.07.026
7. Postic C, Girard J (2008) Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice. J Clin Invest 118:829–838. doi:10.1172/JCI34275
8. Nomura K, Yamanouchi T (2012) The role of fructose-enriched diets in mechanisms of nonalcoholic fatty liver disease. J Nutr Biochem 23:203–208. doi:10.1016/j.jnutbio.2011.09.006
9. Ackerman Z, Oron-Herman M, Grozovski M et al (2005) Fructose-induced fatty liver disease: hepatic effects of blood pressure and plasma triglyceride reduction. Hypertension 45:1012–1018. doi:10.1161/01.HYP.0000164570.20420.67
10. Armutcu F, Coskun O, Gürel A et al (2005) Thymosin alpha 1 attenuates lipid peroxidation and improves fructose-induced steatohepatitis in rats. Clin Biochem 38:540–547. doi:10.1016/j.clinbiochem.2005.01.013
11. Kanuri G, Spruss A, Wagnerberger S et al (2011) Role of tumor necrosis factor α (TNFα) in the onset of fructose-induced nonalcoholic fatty liver disease in mice. J Nutr Biochem 22:527–534. doi:10.1016/j.jnutbio.2010.04.007
12. Haas JT, Miao J, Chanda D et al (2012) Hepatic insulin signaling is required for obesity-dependent expression of SREBP-1c mRNA but not for feeding-dependent expression. Cell Metab 15:873–884. doi:10.1016/j.cmet.2012.05.002
13. Collison KS, Maqbool ZM, Inglis AL et al (2010) Effect of dietary monosodium glutamate on HFCS-induced hepatic steatosis: expression profiles in the liver and visceral fat. Obesity (Silver Spring) 18:1122–1134. doi:10.1038/oby.2009.502
14. Dong X, Park S, Lin X et al (2006) Irs1 and Irs2 signaling is essential for hepatic glucose homeostasis and systemic growth. J Clin Invest 116:101–114. doi:10.1172/JCI25735
15. Kubota N, Kubota T, Itoh S et al (2008) Dynamic functional relay between insulin receptor substrate 1 and 2 in hepatic insulin signaling during fasting and feeding. Cell Metab 8:49–64. doi:10.1016/j.cmet.2008.05.007
16. Zhao CX, Xu X, Cui Y et al (2009) Increased endothelial nitric-oxide synthase expression reduces hypertension and hyperinsulinemia in fructose-treated rats. J Pharmacol Exp Ther 328:610–620. doi:10.1124/jpet.108.143396
17. Xu X, Zhao CX, Wang L et al (2010) Increased CYP2J3 expression reduces insulin resistance in fructose-treated rats and db/db mice. Diabetes 59:997–1005. doi:10.2337/db09-1241
18. Xu X, Tu L, Wang L et al (2011) CYP2J3 gene delivery reduces insulin resistance via upregulation of eNOS in fructose-treated rats. Cardiovasc Diabetol 10:114. doi:10.1186/1475-2840-10-114
19. González-Rodríguez A, Mas Gutierrez JA, Sanz-González S et al (2010) Inhibition of PTP1B restores IRS1-mediated hepatic insulin signaling in IRS2-deficient mice. Diabetes 59:588–599. doi:10.2337/db09-0796
20. Baur JA, Pearson KJ, Price NL et al (2006) Resveratrol improves health and survival of mice on a high-calorie diet. Nature 444:337–342. doi:10.1038/nature05354
21. Lagouge M, Argmann C, Gerhart-Hines Z et al (2006) Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 127:1109–1122. doi:10.1016/j.cell.2006.11.013
22. Sheludiakova A, Rooney K, Boakes RA (2012) Metabolic and behavioural effects of sucrose and fructose/glucose drinks in the rat. Eur J Nutr 51:445–454. doi:10.1007/s00394-011-0228-x
23. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275
24. Towbin H, Staehelin T, Gordon J (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A 76:4350–4354
25. Ouyang X, Cirillo P, Sautin Y et al (2008) Fructose consumption as a risk factor for non-alcoholic fatty liver disease. J Hepatol 48:993–999. doi:10.1016/j.jhep.2008.02.011
26. Brown MS, Goldstein JL (2008) Selective versus total insulin resistance: a pathogenic paradox. Cell Metab 7:95–96. doi:10.1016/j.cmet.2007.12.009
27. Spruss A, Kanuri G, Uebel K et al (2011) Role of the inducible nitric oxide synthase in the onset of fructose-induced steatosis in mice. Antioxid Redox Signal 14:2121–2135. doi:10.1089/ars.2010.3263
28. Kim F, Pham M, Maloney E et al (2008) Vascular inflammation, insulin resistance, and reduced nitric oxide production precede the onset of peripheral insulin resistance. Arterioscler Thromb Vasc Biol 28:1982–1988. doi:10.1161/ATVBAHA.108.169722
29. Pfluger PT, Herranz D, Velasco-Miguel S et al (2008) Sirt1 protects against high-fat diet-induced metabolic damage. Proc Natl Acad Sci USA 105:9793–9798. doi:10.1073/pnas.0802917105
30. Ponugoti B, Kim D-H, Xiao Z et al (2010) SIRT1 deacetylates and inhibits SREBP-1C activity in regulation of hepatic lipid metabolism. J Biol Chem 285:33959–33970. doi:10.1074/jbc.M110.122978
31. Sun C, Zhang F, Ge X et al (2007) SIRT1 improves insulin sensitivity under insulin-resistant conditions by repressing PTP1B. Cell Metab 6:307–319. doi:10.1016/j.cmet.2007.08.014
32. Fröjdö S, Durand C, Molin L et al (2011) Phosphoinositide 3-kinase as a novel functional target for the regulation of the insulin signaling pathway by SIRT1. Mol Cell Endocrinol 335:166–176. doi:10.1016/j.mce.2011.01.008
33. Deng J-Y, Hsieh P-S, Huang J-P et al (2008) Activation of estrogen receptor is crucial for resveratrol-stimulating muscular glucose uptake via both insulin-dependent and -independent pathways. Diabetes 57:1814–1823. doi:10.2337/db07-1750
34. Kang W, Hong HJ, Guan J et al (2012) Resveratrol improves insulin signaling in a tissue-specific manner under insulin-resistant conditions only: in vitro and in vivo experiments in rodents. Metabolism 61:424–433. doi:10.1016/j.metabol.2011.08.003
35. Zhang J (2006) Resveratrol inhibits insulin responses in a SirT1-independent pathway. Biochem J 397:519–527. doi:10.1042/BJ20050977
36. Zeng G, Nystrom FH, Ravichandran LV et al (2000) Roles for insulin receptor, PI3-kinase, and Akt in insulin-signaling pathways related to production of nitric oxide in human vascular endothelial cells. Circulation 101:1539–1545
37. Wang G-L, Fu Y-C, Xu W-C et al (2009) Resveratrol inhibits the expression of SREBP1 in cell model of steatosis via Sirt1-FOXO1 signaling pathway. Biochem Biophys Res Commun 380:644–649. doi:10.1016/j.bbrc.2009.01.163
38. Fujimoto M, Shimizu N, Kunii K et al (2005) A role for iNOS in fasting hyperglycemia and impaired insulin signaling in the liver of obese diabetic mice. Diabetes 54:1340–1348